Dong Lin-Lin, Chen Zhong-Jian, Wang Yong, Wei Fu-Gang, Zhang Lian-Juan, Xu Jiang, Wei Guang-Fei, Wang Rui, Yang Juan, Liu Wei-Lin, Li Xi-Wen, Yu Yu-Qi, Chen Shi-Lin
Institute of Chinese Materia Media, China Academy of Chinese Medicinal Sciences, Beijing 100700, China.
Institute of Sanqi Research, Wenshan University, Wenshan 663000, China.
Zhongguo Zhong Yao Za Zhi. 2017 Jan;42(1):56-62. doi: 10.19540/j.cnki.cjcmm.2017.0004.
DNA marker-assisted selection of medicinal plants is based on the DNA polymorphism, selects the DNA sequences related to the phenotypes such as high yields, superior quality, stress-resistance and so on according to the technologies of molecular hybridization, polymerase chain reaction and high-throughput sequencing, and assists the breeding of new cultivars. This study bred the first disease-resistant cultivar of notoginseng "Miaoxiang Kangqi 1" using the technology of DNA marker-assisted selection of medicinal plants and systematic breeding. The disease-resistant cultivar of notoginseng contained 12 special SNPs based on the analysis of Restriction-site Associated DNA Sequencing (RAD-Seq). Among the SNP (record_519688) was related to the root rot-resistant characteristics, which indicated this SNP could serve as genetic markers of disease-resistant cultivars and assist the systematic breeding. Compared to the conventional cultivated cultivars, the incidence rate of root-rot and rust-rot in notoginseng seedlings decreased by 83.6% and 71.8%, respectively. The incidence rate of root-rot respectively declined by 43.6% and 62.9% in notoginseng cultivation for 2 and 3 years compared with those of the conventional cultivated cultivars. Additionally, the potential disease-resistant groups were screened based on the relative SNP, and this model enlarged the target groups and advanced the breeding efficiency. DNA marker-assisted selection of medicinal plants accelerated the breeding and promotion of new cultivars, and guaranteed the healthy development of Chinese medicinal materials industry.
药用植物的DNA分子标记辅助选择是基于DNA多态性,依据分子杂交、聚合酶链式反应和高通量测序等技术,筛选与高产、优质、抗逆等表型相关的DNA序列,辅助新品种培育。本研究利用药用植物DNA分子标记辅助选择技术和系统选育方法,培育出首个三七抗病品种“妙香抗七1号”。基于简化基因组测序(RAD-Seq)分析,三七抗病品种含有12个特异的单核苷酸多态性位点(SNP)。其中一个SNP(record_519688)与抗根腐病特性相关,表明该SNP可作为抗病品种的遗传标记,辅助系统选育。与传统栽培品种相比,三七种苗根腐病和锈腐病发病率分别降低了83.6%和71.8%。三七种植2年和3年时,根腐病发病率与传统栽培品种相比分别下降了43.6%和62.9%。此外,基于相关SNP筛选出潜在抗病群体,该模式扩大了目标群体,提高了育种效率。药用植物DNA分子标记辅助选择加速了新品种的选育与推广,保障了中药材产业的健康发展。